Published today! 📰
@NatureMedicine
One of the first #cancer vaccines💉that target #KRAS. Not just G12C.
👇🏾The 2-peptide was G12D & R.
The 7-Peptide/Elicio targets
D
R
V
S
A
C
G13
➕
NRAS
Implications for so many patients!
Open now.
Cheers!
@OncoAlert
https://t.co/YYHfJrtQ9U
How could artificial intelligence help unlock personalized cancer vaccines? "Cancer is deeply personal, and it is high time its treatment become personal, too," Drs. Türeci and Sahin of @BioNTech_Group emphasize in @nytimes: https://t.co/a3UiRkrW1n #CancerVaccine#CancerResearch
Biotech Entrepreneur and Venture Capitalist Dinesh Patel Discusses Therapeutics and Medical Devices with CancerVAX CEO Ryan Davies https://t.co/KmdoDqE9hn
LAPIX Therapeutics Inc. Announces the Issuance of U.S. Patent for LPX-TI641, Its First-in-Class, Orally Administered Tim3/4 Agonist for Treg Expansion to Treat Autoimmune Diseases https://t.co/bFYy8xD67g
Umoja Biopharma Presents New Preclinical Data at the American Society of Gene and Cell Therapy 26th Annual Meeting Demonstrating Potent In Vivo CAR T Cell Generation and Durable Anti-Tumor Activity https://t.co/GmQmEEi1pn
Immutep’s Efti in Combination with Pembrolizumab Achieves Excellent Initial Overall Survival Benefit in 1st Line Non-Small Cell Lung Cancer https://t.co/MIDCK7xSS3
Dyne Therapeutics’ Preclinical Data Demonstrating FORCE™ Platform Delivery to CNS Featured in Oral Presentation at ASGCT Annual Meeting https://t.co/ON7XztVcmt
TScan Therapeutics Presents Preliminary Phase 1 Clinical Results on TSC-100 and TSC-101 at the American Society of Gene & Cell Therapy 26th Annual Meeting https://t.co/FGCJLltzHM
Notable Labs to Present Predictive Precision Medicine Platform (PPMP) Data in Juvenile Myelomonocytic Leukemia (JMML) at European Hematology Association (EHA) Hybrid Congress June 8 – 15, 2023 https://t.co/4glvWoW0cr